Dr. Anna Postolova, MD

Dr. Postolova practices at Menlo Medical Clinic - Menlo Park (Crane St) in Menlo Park, California.

Dr. Postolova's NPI, 1932475316, was assigned on March 29, 2012. Dr. Postolova graduated from Tulane School of Medicine in 2012. Dr. Postolova holds California license A126882.

Dr. Postolova's primary practice is Menlo Medical Clinic - Menlo Park (Crane St), at 1300 Crane St, Menlo Park, CA 94025. The practice phone is (650) 498-6530.

Dr. Postolova's primary practice is Menlo Medical Clinic - Menlo Park (Crane St) in Menlo Park, California. Dr. Postolova is also affiliated with Stanford Hospital at 300 Pasteur Drive. The medical group on file is Stanford Medicine Partners. Dmand AI also links Dr. Postolova to 1 more group practice or clinic and 1 medical group, each named with a free account. Dr. Postolova's employer is on file too: a breast imaging center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Postolova practices, 3 sites in all. Vendor and product names are available with a free account.

Allergy and immunology is Dr. Postolova's primary specialty in the NPI Registry, under taxonomy code 207K00000X. Dr. Postolova is board certified in allergy & immunology by the American Board of Allergy and Immunology. Dr. Postolova is licensed in California.

Dmand AI lists asthma, chronic nasal allergies, chronic sinusitis, hives and immune deficiency disease among the conditions Dr. Postolova treats.

CMS data shows 2,455 Medicare services from Dr. Postolova across 9 procedure codes in 2024, for 158 Medicare patients. Medicare paid $105,106 for them. Every service was in an office.

CMS counts 158 Medicare patients who saw Dr. Postolova in 2024. The largest group is 65 to 74, with 67 patients. 70% of them have high cholesterol, and 64% have arthritis. Their average risk score is 1.34, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Postolova's median patient age at 48, with 66% women.

In 2024, Dr. Postolova wrote 516 Medicare Part D claims for 129 patients. 66% of them were for generic drugs. CMS names the drug for 311 of them, across 14 drugs with 11 or more claims each, at $427,997 in total drug cost. In 2023, CMS named 222 claims across 12 drugs.

Dr. Postolova accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Postolova as offering telehealth.

Dmand AI links 8 papers to Dr. Postolova, published from 2013 to 2019. Dr. Postolova has published most often in J Gen Intern Med. Dr. Postolova's most frequent co-authors are Rohit Aggarwal, MD, Lorinda Susan Chung, MD and David Franklin Fiorentino, MD.

CMS Open Payments shows 44 general payments to Dr. Postolova from 14 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 59% of the total. Progentec Diagnostics, Inc. paid the most, $2,400.

Dmand AI lists 1 award for Dr. Postolova, most recently AOA Inductee 2011 in 2011.

Dr. Postolova graduated from Tulane School of Medicine in 2012. Dr. Postolova is a member of AOA.

Dr. Postolova is in network with 6 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. HMO plans come from the most carriers, 3. Check the plan with the practice before a visit.